Early view articles

Diabetes Distilled: Impact of ethnicity, migration and mental health on type 2 diabetes incidence

Being a migrant to the UK increases risk of type 2 diabetes, independently of ethnicity, mental health conditions and other known risk factors.

6 Jul 2026

Conference over coffee: The initial type 2 diabetes consultation, and early-onset type 2 diabetes

Key take-home points from the first two sessions of the 3rd London Conference of the PCDO Society.

6 Jul 2026

PCDO Society Committee elections (2026): Call for candidates

Applications are now open to stand for election to the PCDO Society Committee.

3 Jul 2026

How and when to support carbohydrate counting in type 2 diabetes

A tiered approach to carbohydrate education in type 2 diabetes with three levels according to individual circumstances.

29 Jun 2026

ADA 2026 highlights: Therapies in development for type 2 diabetes, obesity, dyslipidaemia and liver disease

Highlights from the 2026 Scientific Sessions of the American Diabetes Association, held in New Orleans on 5–8 June.

25 Jun 2026

Diabetes Distilled: ESC consensus on ultra-processed foods and cardiovascular disease

High intake of ultra-processed foods associated with cardiovascular morbidity and mortality. How can we mitigate this risk?

25 Jun 2026

Latest events & on-demand videos

National PCDOS 2026

NCC, Birmingham

Join us face-to-face in Birmingham

18-19 November 2026

Face-to-Face

Northern Ireland PCDOS 2026

Hilton Templepatrick, Belfast

Join us face-to-face in Belfast

17 September 2026

Face-to-Face

PCDOS Smart Updates 2026

London

Join us face-to-face

9 September 2026

Face-to-Face

Latest published articles

Editorial: New roles and resources for incretin therapies

Jane Diggle reflects on the growing role of incretin-based therapies across cardio–renal–metabolic care, and highlights resources to support their use.

12 May 2026

Wraparound care for tirzepatide for the management of obesity: What does primary care need to know?

Requirements for wraparound care for tirzepatide in primary care for the management of obesity, and resources from NHS England.

12 May 2026

Prescribing pearls: Semaglutide and tirzepatide for weight management

Indications, effects and prescribing tips for the injectable incretin therapies licensed for weight management.

12 May 2026

Supporting adherence in diabetes care

The importance of medication adherence, and how to assess and support it.

12 May 2026

Development of educational resources for patients and clinicians on injectable therapies with cardiovascular benefits

Sharing innovation in clinical practice: Educational videos and leaflets from the ESC, for healthcare professionals and patients.

12 May 2026

How to assess fitness to drive

Updated April 2026: Advice for healthcare professionals based on the DVLA’s Assessing Fitness to Drive guidance.

12 May 2026

Prescribing cascades and people living with type 2 diabetes

This illustrative case study describes an inadvertent "prescribing cascade", and the actions taken to reduce the resulting polypharmacy and side effects.

12 May 2026

Interactive case study: Mental health and diabetes

Mental health issues in diabetes, including depression, severe mental illness and diabetes distress.

12 May 2026

PCDO Society National Conference 2026: Request for poster abstracts

Poster abstract submissions are invited for the 22^nd National Conference of the PCDO Society, which will be held on 18 and 19 November.

12 May 2026

Diabetes Distilled: Weight regain after stopping newer weight management drugs is faster than anticipated

Weight returns to baseline levels an average estimated 1.5 years after stopping semaglutide or tirzepatide.

12 May 2026

Diabetes Distilled: Greater reductions in HbA1c ACHIEVEd with orforglipron versus oral semaglutide 14 mg

Greater efficacy at the cost of more adverse events in this developmental oral GLP-1 receptor agonist.

12 May 2026

Diabetes Distilled: Incretin therapies and endoscopy safety

Risk of residual gastric volume seen in people taking injectable incretin agents prior to endoscopy.

12 May 2026